Novo Nordisk: Danish economy gets boost from weight-loss drug maker, ET HealthWorld
Novo Nordisk's net profit soared by 51 percent in 2023 to 83.7 billion kroner ($12.1 billion) as sales of diabetes medication Ozempic and obesity drug Wegovy have boomed.